Eni, Oxy & Kogas seal Iraq deal

Three major oil and gas companies have sealed a deal with Iraq’s South Oil Company and Missan Oil Company that is set to increase production by 1 million barrels per day (bbl/d) over the next six years.

Hand shake

The consortium, consisting of the Italian oil and gas company Eni, exploration and production firm Occidental Petroleum (Oxy) and South Korea's Kogas, has pledged $20 billion over the life of the 20-year technical service contract, in order to redevelop the Zubair field, located near Basra in southern Iraq, according to an official statement by Eni.

The contract could be extended by five more years.

Eni owns 32.81% of the project, while Oxy owns 23.44%, Kogas 18.75% and Missan (25%). The group

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

Chartis Energy50 2023

The latest iteration of Chartis' Energy50 2023 ranking and report considers the key issues in today’s energy space, and assesses the vendors operating within it

2021 brings big changes to the carbon market landscape

ZE PowerGroup Inc. explores how newly launched emissions trading systems, recently established task forces, upcoming initiatives and the new US President, Joe Biden, and his administration can further the drive towards tackling the climate crisis

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here